• Ball J, Carrington MJ, McMurray JJV, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167:1807–24.

    PubMed 
    Article 

    Google Scholar
     

  • Wong CX, Brown A, Tse HF, Albert CM, Kalman J, Marwick TH, Lau DH, Sanders P. Epidemiology of atrial fibrillation: the Australian and Asia-Pacific perspective. Heart Lung Circ. 2017;26:870–9.

    PubMed 
    Article 

    Google Scholar
     

  • Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837–47.

    PubMed 
    Article 

    Google Scholar
     

  • Emdin CA, Wong CX, Hsiao AJ, Altman DG, Peters SA, Woodward M, Odutayo AA. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ. 2016;532:h7013.

    PubMed 
    Article 
    CAS 

    Google Scholar
     

  • Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner M, Van Gelder I, Ellinor P, Benjamin E. Symptoms and functional status of patients with atrial fibrillation state of the art and future research opportunities. Circulation. 2012;125:2933–43.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Gallagher C, Hendriks JM, Giles L, Karnon J, Pham C, Elliott AD, Middeldorp ME, Mahajan R, Lau DH, Sanders P, Wong CX. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart. 2019;105:1358–63.

    PubMed 
    Article 

    Google Scholar
     

  • Wong CX, Brooks AG, Leong DP, Roberts-Thomson KC, Sanders P. The increasing burden of atrial fibrillation compared to heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia. Arch Intern Med. 2012;172:739–41.

    PubMed 
    Article 

    Google Scholar
     

  • Tu SJ, Hanna-Rivero N, Elliott AD, Clarke N, Huang S, Pitman BM, Gallagher C, Linz D, Mahajan R, Lau DH, Sanders P, Wong CX. Associations of anemia with stroke, bleeding, and mortality in atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2021;32:686–94.

    PubMed 
    Article 

    Google Scholar
     

  • Bonde AN, Blanche P, Staerk L, Gerds TA, Gundlund A, Gislason G, Torp-Pedersen C, Lip GYH, Hlatky MA, Olesen JB. Oral anticoagulation among atrial fibrillation patients with anemia: an observational cohort study. Eur Heart J. 2019;40:3782–90.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Westenbrink BD, Alings M, Connolly SJ, Eikelboom J, Ezekowitz MD, Oldgren J, Yang S, Pongue J, Yusuf S, Wallentin L, van Gilst WH. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial. J Thromb Haemost. 2015;13:699–707.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Westenbrink BD, Alings M, Granger CB, Alexander JH, Lopes RD, Hylek EM, Thomas L, Wojdyla DM, Hanna M, Keltai M, Steg PG, De Caterina R, Wallentin L, van Gilst WH. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140–9.

    PubMed 
    Article 

    Google Scholar
     

  • Woo-Hyun L, Eue-Keun C, Kyung-Do H, So-Ryoung L, Myung-Jin C, Seil O. Impact of hemoglobin levels and their dynamic changes on the risk of atrial fibrillation: a nationwide population-based study. Sci Rep. 2020;10:1–8.

    Article 
    CAS 

    Google Scholar
     

  • Xu DZ, Murakoshi N, Sairenchi T, Irie F, Igarashi M, Tomizawa T, Yamaguchi I, Iso H, Ota H, Aonuma K. Reduced kidney function and anemia as risk factors for new onset AF. Eur Heart J. 2013;34:P4271–P4271.

    Article 

    Google Scholar
     

  • Kim M, Hong M, Kim JY, Kim IS, Yu HT, Kim TH, Uhm JS, Joung B, Lee MH, Pak HN. Clinical relationship between anemia and atrial fibrillation recurrence after catheter ablation without genetic background. Int J Cardiol Heart Vasc. 2020;27:100507.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Von Haehling S, Jankowska E, Anker S. Anemia in heart failure: an overview of current concepts. Future Cardiol. 2011;7:119–29.

    Article 

    Google Scholar
     

  • Wong CCY, Ng ACC, Kritharides L, Sindone AP. Iron deficiency in heart failure: looking beyond anemia. Heart Lung Circ. 2016;25:209–16.

    PubMed 
    Article 

    Google Scholar
     

  • Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJV, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872–80.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Filippatos G, McMurray JJV, Aboyans V, Achenbach S, Agewall S, Al-Attar N, Atherton JJ, Bauersachs J, John Camm A, Carerj S, Ceconi C, Coca A, Elliott P, Erol Ç, Ezekowitz J, Fernández-Golfín C, Fitzsimons D, Guazzi M, Guenoun M, Hasenfuss G, Hindricks G, Hoes AW, Iung B, Jaarsma T, Kirchhof P, Knuuti J, Kolh P, Konstantinides S, Lainscak M, Lancellotti P, Lip GYH, Maisano F, Mueller C, Petrie MC, Piepoli MF, Priori SG, Torbicki A, Tsutsui H, van Veldhuisen DJ, Windecker S, Yancy C, Zamorano JL, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Dean V, Gaemperli O, Roffi M, Vaz Carneiro A, Sisakian HS, Isayev E, Kurlianskaya A, Mullens W, Tokmakova M, Agathangelou P, Melenovsky V, Wiggers H, Hassanein M, Uuetoa T, Lommi J, Kostovska ES, Juillière Y, Aladashvili A, Luchner A, Chrysohoou C, Nyolczas N, Thorgeirsson G, Marc Weinstein J, Di Lenarda A, Aidargaliyeva N, Bajraktari G, Beishenkulov M, Kamzola G, Abdel-Massih T, Čelutkienė J, Noppe S, Cassar A, Vataman E. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200.

    PubMed 
    Article 

    Google Scholar
     

  • Odutayo A, Wong C, Hsiao A, Hopewell S, Altman DG, Emdin C. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ Br Med J. 2016;354:i4482.

    Article 

    Google Scholar
     

  • Lau DH, Kalman J, Sanders P. Management of recent-onset sustained atrial fibrillation: pharmacologic and nonpharmacologic strategies. Clin Ther. 2014;36:1151–9.

    PubMed 
    Article 

    Google Scholar
     

  • Hohnloser SH. Stroke prevention versus bleeding risk in atrial fibrillation: a clinical dilemma. J Am Coll Cardiol. 2011;57:181–3.

    PubMed 
    Article 

    Google Scholar
     

  • Gleason KT, Nazarian S, Dennison Himmelfarb CR. Atrial fibrillation symptoms and sex, race, and psychological distress: a literature review. J Cardiovasc Nurs. 2018;33:137–43.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Sears SF, Serber ER, Alvarez LG, Schwartzman DS, Hoyt RH, Ujhelyi MR. Understanding atrial symptom reports: objective versus subjective predictors. Pacing Clin Electrophysiol. 2005;28:801–7.

    PubMed 
    Article 

    Google Scholar
     

  • Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Rohl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Eur Heart J. 2009;30:1411–20.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997;30:1039–45.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Daoud EG, Weiss R, Bahu M, Knight BP, Bogun F, Goyal R, Harvey M, Strickberger SA, Man KC, Morady F. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol. 1996;78:1433–6.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Lau CP, Leung WH, Wong CK, Cheng CH. Haemodynamics of induced atrial fibrillation: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J. 1990;11:219–24.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Skinner NS Jr, Mitchell JH, Wallace AG, Sarnoff SJ. Hemodynamic consequences of atrial fibrillation at constant ventricular rates. Am J Med. 1964;36:342–50.

    PubMed 
    Article 

    Google Scholar
     

  • Metivier F, Marchais SJ, Guerin AP, Pannier B, London GM. Pathophysiology of anemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15:14–8.

    PubMed 
    Article 

    Google Scholar
     

  • Singh SN, Tang XC, Singh BN, Dorian P, Reda DJ, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Lopez B, Raisch DW, Ezekowitz MD. Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation. J Am Coll Cardiol. 2006;48:721–30.

    PubMed 
    Article 

    Google Scholar
     

  • Swank AM, Horton J, Fleg JL, Fonarow GC, Keteyian S, Goldberg L, Wolfel G, Handberg EM, Bensimhon D, Illiou MC, Vest M, Ewald G, Blackburn G, Leifer E, Cooper L, Kraus WE. Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training. Circ Heart Fail. 2012;5:579–85.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Vanhees L, Schepers D, Defoor J, Brusselle S, Tchursh N, Fagard R. Exercise performance and training in cardiac patients with atrial fibrillation. J Cardiopulm Rehabil. 2000;20:346.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Hegbom F, Stavem K, Sire S, Heldal M, Orning OM, Gjesdal K. Effects of short-term exercise training on symptoms and quality of life in patients with chronic atrial fibrillation. Int J Cardiol. 2007;116:86–92.

    PubMed 
    Article 

    Google Scholar
     

  • Katsumata Y, Tamura Y, Kimura T, Kohsaka S, Sadahiro T, Nishiyama T, Aizawa Y, Azuma K, Fukuda K, Takatsuki S. A high BNP level predicts an improvement in exercise tolerance after a successful catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:2283–90.

    PubMed 
    Article 

    Google Scholar
     

  • Mohanty S, Santangeli P, Mohanty P, Biase LD, Holcomb S, Trivedi C, Bai R, Burkhardt D, Hongo R, Hao S, Beheiry S, Santoro F, Forleo G, Gallinghouse JG, Horton R, Sanchez JE, Bailey S, Hranitzky PM, Zagrodzky J, Natale A. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014;25:1057–64.

    PubMed 
    Article 

    Google Scholar
     

  • Singh BN, Singh SN, Reda DJ, Tang XC, Lopez B, Harris CL, Fletcher RD, Sharma SC, Atwood JE, Jacobson AK, Lewis HD, Raisch DW, Ezekowitz MD. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med. 2005;352:1861.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Australian health survey: biomedical results for chronic diseases, 2011–12; 2013.

  • McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 2009;12:444–54.

    PubMed 
    Article 

    Google Scholar
     

  • Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89:88–96.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104:2263.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL. Diagnosis and management of iron deficiency anemia: a clinical update. Med J Aust. 2010;193:525–32.

    PubMed 
    Article 

    Google Scholar
     

  • Adou P, Davidsson L, Cook J, Harrell R. Prevalence of iron deficiency with and without concurrent anemia in population groups with high prevalences of malaria and other infections: a study in Cote d’Ivoire. Am J Clin Nutr. 2001;74:776–82.

    PubMed 
    Article 

    Google Scholar
     

  • Callander EJ, Schofield DJ. Is there a mismatch between who gets iron supplementation and who needs it? A cross-sectional study of iron supplements, iron deficiency anemia and socio-economic status in Australia. Br J Nutr. 2016;115:703–8.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ahmed F, Coyne T, Dobson A, McClintock C. Iron status among Australian adults: findings of a population based study in Queensland, Australia. Asia Pac J Clin Nutr. 2008;17:40.

    CAS 
    PubMed 

    Google Scholar
     

  • Vanarsa K, Ye Y, Han J, Xie C, Mohan C, Wu T. Inflammation associated anemia and ferritin as disease markers in SLE. Arthritis Res Ther. 2012;14:R182.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood. 1997;90:4979.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Diagnosis and investigation of iron deficiency anemia. 2017.

  • Rocha BML, Cunha GJL, Menezes Falcão LF. The burden of iron deficiency in heart failure: therapeutic approach. J Am Coll Cardiol. 2018;71:782–93.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Group ESD. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.

  • Von Haehling S, Ebner N, Evertz R, Ponikowski P, Anker SD. Iron deficiency in heart failure. JACC Heart Fail. 2019;7:36–46.

    Article 

    Google Scholar
     

  • Beale AL, Warren JL, Roberts N, Meyer P, Townsend NP, Kaye D. Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis. Open Heart. 2019;6:e001012.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Pozzo J, Fournier P, Delmas C, Vervueren P-L, Roncalli J, Elbaz M, Galinier M, Lairez O. Absolute iron deficiency without anemia in patients with chronic systolic heart failure is associated with poorer functional capacity. Arch Cardiovasc Dis. 2017;110:99–105.

    PubMed 
    Article 

    Google Scholar
     

  • Van Veldhuisen DJ, Ponikowski P, van Der Meer P, Metra M, Böhm M, Doletsky A, Voors AA, Macdougall IC, Anker SD, Roubert B, Zakin L, Cohen-Solal A. Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation. 2017;136:1374.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Anker SD, Kirwan BA, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F, Lüscher TF, Arutyunov GP, Motro M, Mori C, Roubert B, Pocock SJ, Ponikowski P. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. Eur J Heart Fail. 2018;20:125–33.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, Fabien V, Filippatos G, Gohring UM, Keren A, Khintibidze I, Kragten H, Martinez FA, Metra M, Milicic D, Nicolau JC, Ohlsson M, Parkhomenko A, Pascual-Figal DA, Ruschitzka F, Sim D, Skouri H, van der Meer P, Lewis BS, Comin-Colet J, von Haehling S, Cohen-Solal A, Danchin N, Doehner W, Dargie HJ, Motro M, Butler J, Friede T, Jensen KH, Pocock S, Jankowska EA, investigators A-A. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396:1895–1904.

  • Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure. J Am Coll Cardiol. 2011;58:1241–51.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Investig. 2004;113:1271–6.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998;18:555–9.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Lofruthe N, Gallitz I, Traeger L, Baumer N, Schulze I, Kuhlmann T, Muller-Tidow C, Steinbicker AU. Intravenous iron carboxymaltose as a potential therapeutic in anemia of inflammation. PLoS ONE. 2016;11(7):e0158599.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • McDonagh T, Macdougall IC. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral? Eur J Heart Fail. 2015;17:248–62.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2–8.

    Article 

    Google Scholar
     

  • Hu Y-F, Chen Y-J, Lin Y-J, Chen S-A. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230–43.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Schwartz AJ, Converso-Baran K, Michele DE, Shah YM. A genetic mouse model of severe iron deficiency anemia reveals tissue-specific transcriptional stress responses and cardiac remodeling. J Biol Chem. 2019;294:14991–5002.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Puurunen M, Kiviniemi T, Nammas W, Schlitt A, Rubboli A, Nyman K, Karjalainen P, Kirchhof P, Lip GYH, Airaksinen JKE. Impact of anemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry. BMJ Open. 2014;4:e004700.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Westenbrink BD, van Gilst WH, Lopes RD, Thomas L, Wojdyla DM. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2017;185:140–9.

    PubMed 
    Article 

    Google Scholar
     

  • Krittayaphong R, Pumprueg S, Thongsri T, Wiwatworapan W, Choochunklin T, Kaewkumdee P, Yindeengam A, Investigators C-A. Impact of anemia on clinical outcomes of patients with atrial fibrillation: the COOL-AF registry. Clin Cardiol. 2021;44:415–23.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Hashimoto K, Kimura T, Ikemura N, Katsumata Y, Fujisawa T, Miyama H, Yamashita T, Nakamura I, Mano Y, Oki T, Fukuda K, Kohsaka S, Takatsuki S. Burden of mild (<13 g/dl) anemia in patients with atrial fibrillation (a report from a multicenter registry with patient-reported outcomes). Am J Cardiol. 2021;157:48–55.

    PubMed 
    Article 

    Google Scholar
     

  • An Y, Ogawa H, Esato M, Ishii M, Iguchi M, Masunaga N, Fujino A, Ide Y, Hamatani Y, Doi K, Ikeda S, Ishigami K, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M, Fushimi AFRI. Cardiovascular events and mortality in patients with atrial fibrillation and anemia (from the Fushimi AF registry). Am J Cardiol. 2020;134:74–82.

  • Bassand J-P, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AGG, Verheugt FWA, Kakkar AK, Investigators G-A. Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J. 2016;37:2882–9.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • An Y, Ogawa H, Yamashita Y, Ishii M, Iguchi M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M. Causes of death in Japanese patients with atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Eur Heart J Qual Care Clin Outcomes. 2019;5:35–42.

    PubMed 
    Article 

    Google Scholar
     

  • Anker SD, Voors A, Okonko D, Clark AL, James MK, von Haehling S, Kjekshus J, Ponikowski P, Dickstein K, for the OI. Prevalence, incidence, and prognostic value of anemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J. 2009;30:1331–1339.

  • Keskin M, Ural D, Altay S, Argan O, Börklü EB, Kozan Ö. Iron deficiency and hematinic deficiencies in atrial fibrillation: a new insight into comorbidities. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir. 2018;46:103.


    Google Scholar
     

  • Imai R, Higuchi T, Morimoto M, Koyamada R, Okada S. Iron deficiency anemia due to the long-term use of a proton pump inhibitor. Internal Med (Tokyo, Japan). 2018;57:899.

    CAS 
    Article 

    Google Scholar
     

  • Lopez A, Cacoub P, Macdougall IC, Peyrin-Biroulet L. Iron deficiency anemia. Lancet. 2016;387:907–16.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Minhas AMK, Sagheer S, Shekhar R, Sheikh AB, Nazir S, Ullah W, Khan MZ, Shahid I, Dani SS, Michos ED, Fudim M. Trends and inpatient outcomes of primary atrial fibrillation hospitalizations with underlying iron deficiency anemia: an analysis of the national inpatient sample database from 2004–2018. Curr Probl Cardiol. 2021;101001.

  • Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest. 2006;130:1390–6.

    PubMed 
    Article 

    Google Scholar
     

  • Sharma S, Gage BF, Deych E, Rich MW. Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation. Am Heart J. 2009;157:1057–63.

    PubMed 
    Article 

    Google Scholar
     

  • Park SJ, Lee SC, Jang SY, Chang SA, Choi JO, Park SW, Oh JK. E/e’ ratio is a strong prognostic predictor of mortality in patients with non-valvular atrial fibrillation with preserved left ventricular systolic function. Circ J. 2011;75:2350–6.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T. A new scoring system for evaluating the risk of heart failure events in japanese patients with atrial fibrillation. Am J Cardiol. 2012;110:678–82.

    PubMed 
    Article 

    Google Scholar
     

  • Lip GY, Banerjee A, Lagrenade I, Lane DA, Taillandier S, Fauchier L. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project. Circ Arrhythm Electrophysiol. 2012;5:941–8.

    PubMed 
    Article 

    Google Scholar
     

  • Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J. 2012;33:1500–10.

    PubMed 
    Article 

    Google Scholar
     

  • Manzano-Fernandez S, Cambronero F, Caro-Martinez C, Hurtado-Martinez JA, Marin F, Pastor-Perez FJ, Mateo-Martinez A, Sanchez-Martinez M, Pinar-Bermudez E, Valdes M. Mild kidney disease as a risk factor for major bleeding in patients with atrial fibrillation undergoing percutaneous coronary stenting. Thromb Haemost. 2012;107:51–8.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Takabayashi K, Takagi D, Hamatani Y, Unoki T, Esato M, Chun Y, Wada H, Hasegawa K, Abe M, Akao M. Incidence of hospitalization for heart failure in atrial fibrillation patients with anemia: one-year follow-up of the Fushimi AF Registry. Eur Heart J. 2014;35:846.


    Google Scholar
     

  • Goodman SG, Wojdyla DM, Piccini JP, White HD, Paolini JF, Nessel CC, Berkowitz SD, Mahaffey KW, Patel MR, Sherwood MW, Becker RC, Halperin JL, Hacke W, Singer DE, Hankey GJ, Breithardt G, Fox KA, Califf RM, Investigators RA. Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol. 2014;63:891–900.

    PubMed 
    Article 

    Google Scholar
     

  • Sherwood MW, Nessel CC, Hellkamp AS, Mahaffey KW, Piccini JP, Suh EY, Becker RC, Singer DE, Halperin JL, Hankey GJ, Berkowitz SD, Fox KAA, Patel MR. Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial. J Am Coll Cardiol. 2015;66:2271–81.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Lee WH, Hsu PC, Chu CY, Lee HH, Lee MK, Lee CS, Yen HW, Lin TH, Voon WC, Lai WT, Sheu SH, Su HM. Anemia as an independent predictor of adverse cardiac outcomes in patients with atrial fibrillation. Int J Med Sci. 2015;12:618–24.

    CAS 
    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • O’Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, Kowey PR, Mahaffey KW, Chang P, Fonarow GC, Pencina MJ, Piccini JP, Peterson ED. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36:3258–64.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dodson JA, Petrone A, Gagnon DR, Tinetti ME, Krumholz HM, Gaziano JM. Incidence and determinants of traumatic intracranial bleeding among older veterans receiving warfarin for atrial fibrillation. JAMA Cardiol. 2016;1:65–72.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Hori M, Matsumoto M, Tanahashi N, Momomura SI, Uchiyama S, Goto S, Izumi T, Koretsune Y, Kajikawa M, Kato M, Cavaliere M, Iekushi K, Yamanaka S, Investigators JRAS. Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation – Subgroup analysis of J-ROCKET AF. J Cardiol. 2016;68:523–8.

    PubMed 
    Article 

    Google Scholar
     

  • Kobayashi N, Yamawaki M, Nakano M, Hirano K, Araki M, Takimura H, Sakamoto Y, Mori S, Tsutsumi M, Ito Y. A new scoring system (DAIGA) for predicting bleeding complications in atrial fibrillation patients after drug-eluting stent implantation with triple antithrombotic therapy. Int J Cardiol. 2016;223:985–91.

    PubMed 
    Article 

    Google Scholar
     

  • Li G, Thabane L, Delate T, Witt DM, Levine MA, Cheng J, Holbrook A. Can we predict individual combined benefit and harm of therapy? warfarin therapy for atrial fibrillation as a test case. PLoS ONE. 2016;11:e0160713.

    PubMed 
    PubMed Central 
    Article 
    CAS 

    Google Scholar
     

  • Aisenberg J, Chatterjee-Murphy P, Friedman Flack K, Weitz JI, Ruff CT, Nordio F, Mercuri MF, Choi Y, Antman EM, Braunwald E, Giugliano RP. Gastrointestinal bleeding with edoxaban versus warfarin: results from the ENGAGE AF-TIMI 48 trial (effective anticoagulation with factor Xa next generation in atrial fibrillation-thrombolysis in myocardial infarction). Circ Cardiovasc Qual Outcomes. 2018;11:e003998.

    PubMed 
    Article 

    Google Scholar
     

  • Perera KS, Pearce LA, Sharma M, Benavente O, Connolly SJ, Hart RG, Committee AAS, Investigators. Predictors of mortality in patients with atrial fibrillation (from the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events [ACTIVE A]). Am J Cardiol. 2018;121:584–589.

  • An Y, Iguchi M, Ishii M, Masunaga N, Aono Y, Ikeda S, Ishigami K, Doi K, Esato M, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Akao M. Prognostic impact of anemia on stroke/systemic embolism, bleeding, and mortality in patients with atrial fibrillation: the fushimi af registry. Circulation. 2019;140:A12236.


    Google Scholar
     

  • Tiili P, Putaala J, Mehtala J, Khanfir H, Niiranen J, Korhonen P, Raatikainen P, Lehto M. Poor quality of warfarin treatment increases the risk of all types of intracranial hemorrhage in atrial fibrillation. Circ J. 2019;83:540–7.

    CAS 
    PubMed 
    Article 

    Google Scholar
     

  • Kuronuma K, Okumura Y, Yokoyama K, Matsumoto N, Tachibana E, Oiwa K, Matsumoto M, Kojima T, Hanada S, Nomoto K, Arima K, Takahashi F, Kotani T, Ikeya Y, Fukushima S, Itou S, Kondo K, Chiku M, Ohno Y, Onikura M, Hirayama A, Investigators SAR. Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: a SAKURA AF Registry substudy. J Cardiol. 2019;73:210–7.

    PubMed 
    Article 

    Google Scholar
     

  • Fu S, Jiao J, Guo Y, Zhu B, Luo L. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation. BMC Geriatr. 2019;19:56.

    PubMed 
    PubMed Central 
    Article 

    Google Scholar
     

  • Kodani E, Inoue H, Atarashi H, Okumura K, Yamashita T, Origasa H. Impact of hemoglobin concentration and platelet count on outcomes of patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry. Int J Cardiol. 2020;302:81–7.

    PubMed 
    Article 

    Google Scholar
     

  • Zhang Z, Jiang C, He L, Bai Y, Wu J, Hu R, Lv Q, Ning M, Feng L, Tang R, Sang C, Long D, Dong J, Du X, Lip GYH, Ma C. Associations of anemia with death and major bleeding in patients with atrial fibrillation: a report from the Chinese Atrial Fibrillation Registry Study. Clin Cardiol. 2022;45:91–100.

    PubMed 
    Article 

    Google Scholar
     

  • Al-Hussainy N, Kragholm KH, Lundbye-Christensen S, Torp-Pedersen C, Pareek M, Therkelsen SK, Lip GYH, Riahi S. Safety and efficacy of direct oral anticoagulants (DOAC) in patients with anemia and atrial fibrillation: an observational nation-wide Danish cohort study. Eur Heart J Qual Care Clin Outcomes. 2021. https://doi.org/10.1093/ehjqcco/qcab095.

    Article 
    PubMed 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)